L iu Gexin is the chairman of China Keli Group, a diversified company which holds the controlling stake in Sichan Kelun Pharmaceutical, one of China's largest pharmaceutical companies. A former government official, Liu ventured into business in 1996 to found Kelun. The company started as a producer of intravenous solutions, or IV drips, and quickly grew to become the dominant domestic manufacturer in this high-volume, essential medical product segment. This foundational business provided the cash flow for significant expansion and diversification.
Under Liu's leadership, Kelun Pharmaceutical has moved beyond simple IV solutions into more complex and higher-margin areas, investing heavily in research and development for innovative drugs, particularly in the fields of oncology and antibiotics. The company now has a vast portfolio of generic and patented drugs, making it a comprehensive pharmaceutical enterprise. Liu took the company public on the Shenzhen Stock Exchange in 2010, which was the primary driver of his family's considerable fortune. His daughter, Liu Siyi, is also involved in the company's management.
Advertisement
Liu Gexin is a Chinese businessman, the self-made billionaire Founder and Executive Chairman of Tecon Group (and its publicly traded subsidiary Tecon Biology - SZSE: 002100), a major manufacturer of veterinary drugs, animal vaccines, and animal feed. His career is rooted in the essential agribusiness and pharmaceutical sectors.
Liu's philosophical approach centers on scientific innovation, scale manufacturing, and vertical integration across the entire animal health and agribusiness supply chain. He founded Tecon Group in 1992, recognizing the immense, untapped domestic demand for modern, professional veterinary products in China's rapidly growing agricultural sector.
Liu Gexin's strategic genius was his commitment to technological excellence and vertical integration. Under his leadership as Chairman, Tecon Group expanded aggressively, successfully executing its IPO on the Shenzhen Stock Exchange. The company became a market leader in animal vaccines and pharmaceuticals, challenging foreign competitors with high-quality, domestic products. His structural contribution is immense: pioneering the professionalization and industrial scaling of the Chinese animal health sector.
His wealth is secured by the colossal, long-term, stable profitability of the global agribusiness and veterinary pharmaceutical sector.
Advertisement
Graduates with a degree in Veterinary Medicine (Academic Achievement).
Founds Tecon Group (Founding).
Tecon Biology executes its successful IPO on the Shenzhen Stock Exchange (Financial Milestone).
Continues as Founder and Executive Chairman, guiding the massive agribusiness giant (Executive Oversight).
Liu Gexin's wealth is concentrated in his founding equity and continued executive leadership of the publicly traded agribusiness giant, Tecon Biology (SZSE: 002100).
Advertisement
Liu Gexin's social impact is structural, stemming from Tecon Group's role in providing essential veterinary medicines and vaccines that contribute to food safety and animal health in China. The company contributes significantly to the national agribusiness supply chain and food security.
His personal philanthropy supports various community and educational initiatives. His structural contribution is tied to the successful industrialization and scale of the Chinese animal health sector.
Liu Gexin maintains the professional, pragmatic style of an industrial executive. His attire is consistently formal and high-quality, favoring tailored business suits. His aesthetic reflects serious authority and stability, typical of a leader in the specialized agribusiness sector.
Residing in Shenzhen, China, his luxury is the immense security and financial reward derived from his multi-billion dollar fortune. His life is dedicated to industrial scale, quality control, and the long-term, stable growth of the animal health supply chain.
Advertisement
No publicly available quotes.
Advertisement
+0.28% | +$26.44M
-4.56% | -$115.26M
This profile is compiled from verified biographical and financial records:
All information is cross-referenced with public sources for accuracy; some narrative sections are AI-assisted summaries.
If you find any inaccuracies, please report them to admin@redcarpetlife.in
Sponsored Content